Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure

INTRODUCTION: Hydroxychloroquine (HCQ) emerged early in the course of the coronavirus disease 2019 (COVID-19) pandemic as a possible drug with potential therapeutic and prophylactic benefits. It was quickly adopted in China, Europe, and the USA. We systematically reviewed the existing clinical evide...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakedzon, Stav, Khoury, Yara, Rozenberg, Gilad, Neuberger, Ami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2020
Materias:
Special Issue on the COVID-19 Pandemic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426548/
https://www.ncbi.nlm.nih.gov/pubmed/32792041
http://dx.doi.org/10.5041/RMMJ.10416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426548/
https://www.ncbi.nlm.nih.gov/pubmed/32792041
http://dx.doi.org/10.5041/RMMJ.10416

Ejemplares similares